Rapid Fragile X Carrier Screening and Prenatal Diagnosis Using a Nonradioactive PCR Test

JAMA: The Journal of the American Medical Association

Volumn 270, Issue 13, 1993, Pages 1569-1575

  Brown, W Ted ^a   Houck, George E ^a   Jeziorowska, Anna ^a   Levinson, Faye N ^a   Ding, Xiaohua ^a   Dobkin, Carl ^a   Zhong, Nan ^a   Henderson, Jeanine ^a   Brooks, Susan Sklower ^a   Jenkins, Edmund C ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FRAGILE X SYNDROME; GENETIC COUNSELING; HETEROZYGOTE DETECTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MENTAL DEFICIENCY; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCREENING TEST;

BASE SEQUENCE; CHEMILUMINESCENCE; DNA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FRAGILE X SYNDROME; HETEROZYGOTE DETECTION; HUMAN; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE PROBES; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; REPETITIVE SEQUENCES, NUCLEIC ACID; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027375451     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1993.03510130075034     Document Type: Article

References (55)

1. Mandel JL, Hagerman R, Frostier U, et al. Conference Report: Fifth International Workshop on the Fragile X and X-Linked Mental Retardation. Am J Med Genet. 1991;43:5-27.
2. Brown WT, Jenkins EC. The fragile X syndrome. In: Freidman T, ed. Molecular Genetic Medicine. Orlando, Fla: Academic Press Inc; 1992;2:39-66.
3. Blomquist HK, Gustavson KH, Holgrem G, Nordenson I, Palsson-Strae U. Fragile X syndrome in mildly mentally retarded children in a northern Swedish county: a prevalence study. Clin Genet. 1983;24: 393-398.
4. Webb TP, Bundey SE, Thake AI, Todd J. The frequency of the fragile X chromosome among school children in Coventry. J Med Genet. 1986;23:396-399.
5. Sherman SL, Morton NE, Jacobs PA, Turner G. The marker (X) syndrome: a cytogenetic and genetic analysis. Ann Hum Genet. 1984;48:21-37.
6. Sherman SL, Jacobs PA, Morton NE, et al. Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet. 1985;69:289-299.
7. Brown WT, Gross AC, Goonewardena P, Ferrando C, Dobkin C, Jenkins EC. Detection of fragile X non-penetrant males by DNA marker analysis. Am J Med Genet. 1991;38:292-297.
8. Hagerman RJ, Silverman AC, eds. Fragile X Syndrome: Diagnosis, Treatment, and Research. Baltimore, Md: The Johns Hopkins University Press; 1991.
9. Brown WT, Jenkins EC, Goonewardena P, Miezejeski CJ, Devys D. Prenatally detected fragile X females: long-term follow-up studies show high risk of mental impairment. Am J Med Genet. 1992; 43:96-102.
10. Verkerk AJMH, Pieretti M, Sutcliffe JS, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65:905-914.
11. Rousseau F, Heitz D, Biancalana V, et al. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med. 1991;325:1673-1681.
12. Pieretti M, Zhang F, Fu YH, et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991;66:1-20.
13. Caskey CT, Pizzuti A, Fu YH, Fenwick RG, Nelson DL. Triplet repeat mutations in human disease. Science. 1992;256:784-789.
14. Mahadevan M, Tsilfidis C, Sabourin L, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3’ untranslated region of the gene. Science. 1992; 255:1253-1255.
15. La Spada AR, Roling DB, Harding AE, et al. Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat Genet. 1992;2:301-304.
16. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72:971-983.
17. Smits APT, Dreesen JCFM, Post JG, et al. The fragile X syndrome: no evidence for any recent mutations. J Med Genet. 1993;30:94-96.
18. Shelbourne P, Davies J, Buxton J, et al. Direct diagnosis of myotonic dystrophy with a disease-specific DNA marker. N Engl J Med. 1993;328:471-475.
19. Yamagata H, Miki T, Ogihara T, et al. Expansion of unstable DNA region in Japanese myotonic dystrophy patients. Lancet. 1992;339:692.
20. Richards RI, Holman K, Friend K, et al. Evidence of founder chromosomes in fragile X syndrome. Nat Genet. 1992;1:257-260.
21. Oudet C, Mornet E, Serre JL, et al. Linkage disequilibrium between the fragile X mutation and two closely linked CA repeats suggests that fragile X chromosomes are derived from a small number of founder chromosomes. Am J Hum Genet. 1993;52: 297-304.
22. Jenkins EC, Houck GE Jr, Jeziorowska A, et al. Prenatal detection of fragile X: experience of 10 years including introduction to molecular testing. In: Hagerman RJ, McKenzie P, eds. 1992 International Fragile X Conference Proceedings. Dillon Springs, Colo: Spectra Publishing Co Inc; 1992:349-355.
23. Jenkins EC, Shapiro LR, Brown WT. Prenatal diagnosis of the fragile X syndrome. In: Milunsky A, ed. Genetic Disorder and the Fetus: Diagnosis, Prevention and Treatment. 3rd ed. Baltimore, Md: The Johns Hopkins University Press; 1992;241-255.
24. Brown WT, Jenkins EC, Gross AC, et al. Clinical use of DNA markers in the fragile (X) syndrome for carrier detection and prenatal diagnosis. In: Willey AM, ed. Nucleic Acid Probes in Diagnosis of Human Genetic Diseases. New York, NY: Alan R Liss Inc; 1988:11-34.
25. Oostra BA, Jacky PB, Brown WT, Rousseau F. Guidelines for the diagnosis of fragile X syndrome. J Med Genet. 1993;30:410-413.
26. Dobkin CS, Ding XH, Jenkins EC, et al. Prenatal diagnosis of fragile X syndrome. Lancet. 1991;338: 957-958.
27. Hirst M, Knight S, Davies K, et al. Prenatal diagnosis of the fragile X syndrome. Lancet. 1991; 338:956-957.
28. Sutherland GR, Gedeon A, Kornman L, et al. Prenatal diagnosis of fragile X syndrome by direct detection of the unstable DNA sequence. N Engl J Med. 1991;325:1720-1722.
29. Saiki RK, Gelfand DH, Stoffel S, et al. Primerdirected enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988;239:487-491.
30. Markham AF. The polymerase chain reaction: a tool for molecular medicine. BMJ. 1993;306:441-446.
31. Yu S, Pritchard M, Kremer E, et al. Fragile X genotype characterized by an unstable region of DNA. Science. 1991;252:1179-1181.
32. Fu YH, Kuhl DPA, Pizzuti A, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991;67:1047-1058.
33. Pergolizzi RG, Erster SH, Goonewardena P, Brown WT. Detection of full fragile X mutations by polymerase chain reaction. Lancet. 1992;339:271-272.
34. Erster SH, Brown WT, Goonewardena P, Dobkin CS, Jenkins EC, Pergolizzi RG. PCR analysis of fragile X mutations. Hum Genet. 1992;90:55-61.
35. Strauss WM. Preparation of genomic DNA from mammalian tissue. In: Ausubel FM, Brent R, Kinston RE, et al, eds. Current Protocols in Molecular Biology. New York, NY: John Wiley and Sons Inc; 1988;1:2.2.1-2.2.3.
36. Krawczun MS, Duncan CJ, Stark-Houck SL, Jenkins EC. Fra(X) prenatal diagnosis: are endoreduplicated and polyploid cells useful diagnostic criteria? Am J Med Genet. 1992;43:149-154.
37. Rychlik W, Rhoads RE. A computer program for choosing optimal oligonucleotides for filter hybridization, sequencing and in vitro amplification of DNA. Nucleic Acids Res. 1989;17:8543-8551.
38. Walsh PS, Erlich HA, Higuchi R. Preferential PCR amplification of alleles: mechanisms and solutions. PCR Methods Appli. 1992;1:241-250.
39. Bell DA, DeMarini DM. Excessive cycling converts PCR products to random-length higher molecular weight fragments. Nucleic Acids Res. 1991; 19:5079.
40. D'Aquila RT, Bechtel LJ, Videler JA, Eron JJ, Gorczyca P, Kaplan JC. Maximizing sensitivity and specificity of PCR by pre-amplification heating. Nucleic Acids Res. 1991;19:3749.
41. Trnovsky J. Semi-dry electroblotting of DNA and RNA from agarose and polyacrylamid gels. Biotechniques. 1992;13:800-803.
42. Pollard-Knight D, Simmonds AC, Schaap AP, Akhavan H, Brady MA. Nonradioactive DNA detection on Southern blots by enzymatically triggered chemiluminescence. Anal Biochem. 1990;185:353-358.
43. Witt M, Erickson RP. A rapid method for detection of Y-chromosomal DNA from dried blood specimens by the polymerase chain reaction. Hum Genet. 1989;82:271-274.
44. Sutcliffe JS, Nelson DL, Zhang F, et al. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet. 1992;1:397-400.
45. Innis MA. PCR with 7-deaza-2'-deoxyguanosine triphosphate. In: Innis MA, Gelfand DH, Snisky JJ, White TJ, eds. PCR Protocols: A Guide to Methods and Applications. Orlando, Fla: Academic Press Inc; 1990:54-59.
46. Patten JL, Johns DR, Valle D, et al. Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med. 1990;322:1412-1419.
47. Heitz D, Devys D, Imbert G, Kretz C, Mandel JL. Inheritance of the fragile X syndrome: size of the fragile X premutation is a major determinant of the transition to full mutation. J Med Genet. 1992;29: 794-801.
48. Macpherson JN, Nelson DL, Jacobs PA. Frequent small amplification in the FMR-1 gene in fra (X) families: limits to the diagnosis of ‘premutations'. J Med Genet. 1992;29:802-806.
49. Deka R, Chakraborty R, DeCroo S, Rothhammer F, Barton SA, Ferrel RE. Characteristics of polymorphism at a VNTR locus 3’ to the apolipoprotein B gene in five human populations. Am J Hum Genet. 1992;51:1325-1333.
50. Fornage M, Chan L, Siest G, Boerwinkle E. Allele frequency distribution of the (TG)n(AG)m microsatellite in the apolipoprotein C-II gene. Genomics. 1992;12:63-68.
51. Levinson G, Gutman GA. Slipped-strand mispairing: a major mechanism for DNA sequence evolution. Mol Biol Evol. 1987;4:203-221.
52. Moser HW, Ramey CT, Leonard CO. Mental retardation. In: Emery AEH, Rimoin DL, eds. Principles and Practice of Medical Genetics. New York, NY: Churchill Livingstone; 1989;1:495-551.
53. McCabe ERB. Utility of PCR for DNA analysis from dried blood spots on filter paper blotters. PCR Methods Appli. 1991;1:99-106.
54. Turner G, Robinson H, Laing S, et al. Population screening for fragile X. Lancet. 1992;339:1210-1213.
55. Nolin SL, Snider DA, Jenkins EC, et al. Fragile X screening program in New York State. Am J Med Genet. 1991;38:251-255.